Skip to main content

HubXchange

HubXChange logo

Antibody CMC Development Xchange - San Francisco - 2026

Page Banner 1

  1. Quality Control & Characterization
    • Quality Control & Characterization
    Accurately forecasting long-term stability from accelerated data
    Aaron Heib
    Aaron Heib, Director - Genentech
  2. Formulation & Stability
    • Formulation & Stability
    Identifying conditions that trigger denaturation or chemical modifications
    How are companies balancing industry-wide standardization with product-specific tailoring of stress ...
    Da Huang
    Da Huang, Director, Formulation Development - Eyconis
  3. Downstream Processing & Purification
    • Downstream Processing & Purification
    Managing resin fouling and degradation while maintaining high purification efficiency
    Debola Banerjee
    Debola Banerjee, Senior Director, Biotherapeutics CMC - Exilixis
  4. Quality Control & Characterization
    • Quality Control & Characterization
    Current Challenges for QC and Characterization revolving around the shift toward complex biologics, compressed development timelines, and maintaining data integrity
    Monoclonal antibodies, ADC and cell therapies are highly sensitive to environmental conditions, maki ...
    Doan Tran
    Doan Tran, VP of CMC - Tizona Therapeutics
  5. Formulation & Stability
    • Formulation & Stability
    Formulation strategies for physically unstable multi-specific biologics molecules
    Intrinsic multi-specific liabilities: Have we sufficiently built and leveraged cross‑platform learni ...
    Li Yi
    Li Yi, Executive Director, Formulation and Process Development - Gilead Sciences, Inc.
  6. Cell Line Development
    • Cell Line Development
    Identifying your optimal cell line: Finding the needle in the needle stack
    How are next-generation therapeutic modalities (e.g., bispecifics, fusion proteins, non-mAbs) reshap ...

    Kemp Proteins X OneCyte

    Carter Mitchell
    Carter Mitchell, Chief Scientific Officer - Kemp Proteins
    Konstantinos Tsioris
    Konstantinos Tsioris, Co-founder and President - OneCyte
  7. Formulation & Stability
    • Formulation & Stability
    From data to decisions: Computational strategies for de-risking drug product development
    How does molecular complexity translate into formulation and manufacturability challenges? What can ...

    Leukocare

    Cornelius Pompe
    Cornelius Pompe, Chief Operating Officer - Leukocare AG
  8. Upstream Development
    • Upstream Development
    Balancing nutrient supply to maximize productivity without affecting product quality
    How can nutrient supply be optimized to maximize cell growth and productivity without compromising p ...

    FUJIFILM Biosciences

  9. Upstream Development
    • Upstream Development
    How can we accomplish early upstream development while racing to FIH?
  10. Upstream Development
    • Upstream Development
    Poster Presentation: Beyond Fed-Batch: A Practical Guide to Intensified and Perfusion-Based Bioprocessing
    Traditional fed-batch processes have traditionally relied on scale-up to increase production, introd ...

    Just Evotec Biologics

    Aaron Choi
    Aaron Choi, Senior Scientist I - Just - Evotec Biologics
  11. Cell Line Development
    • Cell Line Development
    Poster Presentation: Upstream Development topic: End‑to‑End, GMP‑Compliant Antibody Manufacturing Backed by 100+ Years of Biopharma Expertise
    IDT Biologika is a biopharmaceutical contract development and manufacturing organization with more t ...

    IDT Biologika

    Madhurima Saini
    Madhurima Saini, Global Senior Director of Business Development - IDT Biologika
  12. Downstream Processing & Purification
    • Downstream Processing & Purification
    Balancing robust viral inactivation with product recovery
    How can molecule instability at low pH, including aggregation, fragmentation, or potency loss, be mi ...
    Avneesh Saini
    Avneesh Saini, Senior Director CMC - Radiant Biotherapeutics
  13. Upstream Development
    • Upstream Development
    Developing a high-throughput early developability package to support the pipeline and AI model training
    How should organizations define meaningful developability risk thresholds when there is no clear ind ...
    Tatjana Petojevic
    Tatjana Petojevic, Director, Head of Protein Sciences - Rondo Therapeutics
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Spotlight Presentation:
  15. Cell Line Development
    • Cell Line Development
    Cell line development strategies towards overcoming multispecific expression challenges
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Drinks-Canape Reception
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Afternoon Refreshments
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    1-2-1 Meetings / Networking Break
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    1-2-1 Meetings / Networking Break
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Networking Lunch
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Morning Refreshments
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    1-2-1 Meetings / Networking Break
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    1-2-1 Meetings / Networking Break
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Opening Address & Keynote Presentation:
    • Cell Line Development
    • Upstream Development
    • Downstream Processing & Purification
    • Formulation & Stability
    • Quality Control & Characterization
    Registration
Search